abstract |
Polymorph I of 4- [2- [4- [1- (2-ethoxyethyl) -1H-benzimidazol-2-yl] -1-piperidinyl] ethyl] - (α, α-dimethylbenzeneacetic acid of formula (I) is described, as well as procedures for its preparation, pharmaceutical formulations containing polymorph I and the use of polymorph I to treat allergic reactions and pathological processes mediated by histamine in mammals such as humans. |